Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2019).
A printed edition of this Special Issue is available here.
Interests: organic chemistry; medicinal chemistry; biotransformations; natural products; plant chemical profile; sustainable chemistry
Special Issues and Collections in MDPI journals
Topical Collection in Methods and Protocols: Green Chemistry
Special Issue in Molecules: Marine and Terrestrial Sources of Natural Products: Chemical Composition Profiling, Isolation and Characterization
Special Issue in Marine Drugs: Seaweeds Secondary Metabolites: Successes In and/or Probable Therapeutic Applications 2.0
Special Issue in Pharmaceuticals: Identification of Phytochemicals and Derivatives against Infectious Diseases
Seaweeds are recognized as highly nutritious, and their use in gastronomy is increasing. In fact, their health benefits and their potential to prevent several diseases are also established. Their anticancer, anti-inflammatory, and antihypertensive activities can be mentioned as examples.
Yet, the relationship between those health effects and the secondary metabolites produced has been explored less. Seaweeds grow in environmental conditions, which in some cases are extreme, making them a source of distinctive bioactive natural products. Moreover, examples of lead compounds developed from their unique natural compounds can be found in literature.
This is a good reason to devote a Special Issue of Marine Drugs to the bioactive compounds from seaweeds, and in this Special Issue we would like to revisit and/or update the information on the well-documented bioactive compounds isolated from seaweeds.
As Guest Editor, I invite scientists to submit their latest research findings and review articles in this area, and in doing so contribute to this Special Issue of Marine Drugs with interesting papers showing significant advances in this field.
Prof. Dr. Diana C. G. A. Pinto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.